PureTech Health plc Return on Equity

PureTech Health plc (PRTCY) currently reports a ROE of 13.5%. That is above the Finance sector average of 11.91%. Use the charts on this page to explore PureTech Health plc's ROE history and peer comparisons.

PureTech Health plc's ROE of 13.5% is higher than the Finance sector average of 11.91%. That is roughly 13.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but PureTech Health plc's current 13.5% should be judged against Finance norms (sector average: 11.91%) and against PRTCY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 13.5%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Finance average is 11.91%. From there, open related valuation or income-statement pages for PureTech Health plc, and consider following PRTCY for alerts when major investors trade the stock.

PureTech Health plc is classified in the Finance sector. On ROE, it currently shows 13.5% versus a sector average near 11.91%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Finance are usually more informative than comparing PRTCY with unrelated industries.